Your browser doesn't support javascript.
loading
Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody-drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors: first-in-human dose-escalation study.
Gazzah, A; Bedard, P L; Hierro, C; Kang, Y-K; Abdul Razak, A; Ryu, M-H; Demers, B; Fagniez, N; Henry, C; Hospitel, M; Soria, J-C; Tabernero, J.
Affiliation
  • Gazzah A; Drug Development Department, Gustave Roussy, Villejuif Cedex, Villejuif, France. Electronic address: Anas.gazzah@gustaveroussy.fr.
  • Bedard PL; Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre-University Health Network, University of Toronto, Toronto, Canada.
  • Hierro C; Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain.
  • Kang YK; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Abdul Razak A; Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre-University Health Network, University of Toronto, Toronto, Canada.
  • Ryu MH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Demers B; Early Clinical Development Oncology, Sanofi, Vitry-sur-Seine, France.
  • Fagniez N; Pharmacokinetics, Dynamics and Metabolism, Sanofi, Chilly-Mazarin, France.
  • Henry C; Translational Medicine, Sanofi, Vitry-sur-Seine, France.
  • Hospitel M; Biostatistics and Programming, Sanofi, Vitry-sur-Seine, France.
  • Soria JC; Director General, Gustave Roussy, Villejuif Cedex, Villejuif, France.
  • Tabernero J; Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain; Medical Oncology Department, IOB-Quiron, UVic-UCC, Barcelona, Spain.
Ann Oncol ; 33(4): 416-425, 2022 04.
Article in En | MEDLINE | ID: mdl-35026412
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoconjugates / Antibodies / Neoplasms / Antineoplastic Agents Type of study: Guideline / Prognostic_studies Limits: Adolescent / Adult / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoconjugates / Antibodies / Neoplasms / Antineoplastic Agents Type of study: Guideline / Prognostic_studies Limits: Adolescent / Adult / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article